Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Fischer

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|August 6, 2019
The evolution of the use of faecal microbiota transplantation and emerging therapeutic indicationsJessica R Allegretti, Benjamin H Mullish, Colleen Kelly, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2019
Patients Eligible for Trials of Microbe-Based Therapeutics Do Not Represent the Population With Recurrent Clostridioides difficile InfectionColleen R Kelly, Monika Fischer, Ari Grinspan, et al.
AAPS Pharmscitech|April 2, 2016
Assessment of Small Intestinal Transit Times in Ulcerative Colitis and Crohn's Disease Patients with Different Disease Activity Using Video Capsule EndoscopyMonika Fischer, Shivi Siva, John M Wo, et al.
The Journal of Biological Chemistry|May 31, 2002
Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP)Min You, Monika Fischer, Mark A Deeg, et al.
The American Journal of Gastroenterology|February 4, 2017
Response to Bodiwala and SkoleMonika Fischer, Emmalee Phelps, Dina Kao, et al.
Gut Microbes|January 20, 2017
Can you cause inflammatory bowel disease with fecal transplantation? A 31-patient case-series of fecal transplantation using stool from a donor who later developed Crohn's diseaseMonika Fischer, Mohamad Bittar, Eliseo Papa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 1, 2018
Nuts and Bolts of Fecal Microbiota TransplantationEdward Krajicek, Monika Fischer, Jessica R Allegretti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 1, 2026
AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Adults: Expert ReviewMonika Fischer, Byron P Vaughn, Anne F Peery, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Early Antibiotic Use After Fecal Microbiota Transplantation Increases Risk of Treatment FailureJessica R Allegretti, Dina Kao, Jessica Sitko, et al.
Journal of Clinical Gastroenterology|March 19, 2019
Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT)Jessica R Allegretti, Zain Kassam, Monika Fischer, et al.
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|August 6, 2019
The evolution of the use of faecal microbiota transplantation and emerging therapeutic indicationsJessica R Allegretti, Benjamin H Mullish, Colleen Kelly, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2019
Patients Eligible for Trials of Microbe-Based Therapeutics Do Not Represent the Population With Recurrent Clostridioides difficile InfectionColleen R Kelly, Monika Fischer, Ari Grinspan, et al.
AAPS Pharmscitech|April 2, 2016
Assessment of Small Intestinal Transit Times in Ulcerative Colitis and Crohn's Disease Patients with Different Disease Activity Using Video Capsule EndoscopyMonika Fischer, Shivi Siva, John M Wo, et al.
The Journal of Biological Chemistry|May 31, 2002
Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP)Min You, Monika Fischer, Mark A Deeg, et al.
The American Journal of Gastroenterology|February 4, 2017
Response to Bodiwala and SkoleMonika Fischer, Emmalee Phelps, Dina Kao, et al.
Gut Microbes|January 20, 2017
Can you cause inflammatory bowel disease with fecal transplantation? A 31-patient case-series of fecal transplantation using stool from a donor who later developed Crohn's diseaseMonika Fischer, Mohamad Bittar, Eliseo Papa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 1, 2018
Nuts and Bolts of Fecal Microbiota TransplantationEdward Krajicek, Monika Fischer, Jessica R Allegretti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 1, 2026
AGA Clinical Practice Update on Management of Clostridioides difficile Infection in Adults: Expert ReviewMonika Fischer, Byron P Vaughn, Anne F Peery, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Early Antibiotic Use After Fecal Microbiota Transplantation Increases Risk of Treatment FailureJessica R Allegretti, Dina Kao, Jessica Sitko, et al.
Journal of Clinical Gastroenterology|March 19, 2019
Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT)Jessica R Allegretti, Zain Kassam, Monika Fischer, et al.
Pageof 14